| abstract |
The present invention relates to a high throughput composition (HPC) of a parent compound capable of passing through a biological barrier with high throughput efficiency. The HPC can be converted to the parent drug-related compound, such as parent drug or metabolite, after passing through one or more biological barriers, thereby treating conditions that can be treated by the parent drug or parent drug-related compound. In addition, the HPC allows the parent drug or parent drug-related compound to reach a site where the target site is inaccessible or inadequate. NSAIA's HPC has proven to be a prescription for, for example, hair loss treatment. HPC may be administered to a subject through various routes of administration, for example, local delivery at a high concentration to the site of action of the condition, or systemic administration to a biological subject, which may be introduced at a higher rate to the general circulation. |